Related content

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

By Dent Susan  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 295-310

Springer Publishing Company

Access to resources Recommend Favorite

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials

By Markopoulos Christos  

Cancer and Metastasis Reviews, Vol. 29, Iss. 4, 2010-12 ,pp. : 581-594

Springer Publishing Company

Access to resources Recommend Favorite

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

By Skedgel C.   Rayson D.   Dewar R.   Younis T.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 3, 2007-03 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer

By Sawada Shojiro   Sato Kazuhiko   Kusuhara Masatoshi   Ayaori Makoto   Yonemura Atsushi   Tamaki Kuniyoshi   Hiraide Hoshio   Mochizuki Hidetaka   Ohsuzu Fumitaka  

Acta Oncologica, Vol. 44, Iss. 2, 2005-03 ,pp. : 134-141

Informa Healthcare

Access to resources Recommend Favorite

A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases

By Howell A.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite